Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.57% |
| 2 | Healthcare | 9.66% |
| 3 | Financials | 8.97% |
| 4 | Communication Services | 8.91% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Varonis Systems
VRNS
$5.26B
| $20.1M | ﹤0.01% |
391,485
+150,417
| +62% | +$8.92M |
|
|
SJI
1902
DELISTED
South Jersey Industries, Inc.
SJI
| $20.1M | ﹤0.01% |
889,847
-76,587
| -8% | -$1.81M |
|
1903
WD-40
WDFC
$3.09B
| $20.1M | ﹤0.01% |
65,597
-14,333
| -18% | -$4.35M |
|
1904
Schwab Fundamental US Large Company Index ETF
FNDX
$27.6B
| $20M | ﹤0.01% |
1,163,616
+67,959
| +6% | +$1.11M |
|
|
SAND
1905
DELISTED
Sandstorm Gold
SAND
| $20M | ﹤0.01% |
2,943,042
-878,822
| -23% | -$5.89M |
|
|
HPP
1906
Hudson Pacific Properties
HPP
$787M
| $20M | ﹤0.01% |
105,349
-227,768
| -68% | -$40.7M |
|
1907
iShares Future Exponential Technologies ETF
XT
$4.01B
| $20M | ﹤0.01% |
337,801
+3,998
| +1% | +$238K |
|
1908
Builders FirstSource
BLDR
$7.91B
| $20M | ﹤0.01% |
431,159
-49,065
| -10% | -$2.09M |
|
|
IFN
1909
Aberdeen India Fund
IFN
$505M
| $20M | ﹤0.01% |
931,875
+35,749
| +4% | +$749K |
|
|
DPG
1910
Duff & Phelps Utility and Infrastructure Fund
DPG
$531M
| $19.9M | ﹤0.01% |
1,501,369
-29,152
| -2% | -$382K |
|
1911
Cracker Barrel
CBRL
$1.31B
| $19.9M | ﹤0.01% |
115,177
-20,402
| -15% | -$3.11M |
|
1912
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.21B
| $19.9M | ﹤0.01% |
757,352
-186,467
| -20% | -$4.58M |
|
1913
Molina Healthcare
MOH
$10.7B
| $19.9M | ﹤0.01% |
84,929
-46,347
| -35% | -$10.3M |
|
|
HEQ
1914
John Hancock Hedged Equity & Income Fund
HEQ
$141M
| $19.8M | ﹤0.01% |
1,647,202
+128,572
| +8% | +$1.5M |
|
|
BCPC
1915
Balchem Corp
BCPC
$5.65B
| $19.8M | ﹤0.01% |
158,254
-24,622
| -13% | -$2.99M |
|
1916
TechnipFMC
FTI
$30.1B
| $19.8M | ﹤0.01% |
2,570,420
-616,660
| -19% | -$5.04M |
|
1917
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
| $19.8M | ﹤0.01% |
1,084,237
-160,275
| -13% | -$2.88M |
|
1918
Pacira BioSciences
PCRX
$924M
| $19.8M | ﹤0.01% |
282,195
+51,345
| +22% | +$3.67M |
|
1919
HealthEquity
HQY
$8.83B
| $19.7M | ﹤0.01% |
289,999
+19,625
| +7% | +$1.54M |
|
1920
State Street SPDR S&P Health Care Services ETF
XHS
$207M
| $19.7M | ﹤0.01% |
185,058
-42,160
| -19% | -$4.42M |
|
1921
The RealReal
REAL
$1.33B
| $19.7M | ﹤0.01% |
869,284
-529,757
| -38% | -$13M |
|
|
MAXR
1922
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $19.7M | ﹤0.01% |
520,018
+363,001
| +231% | +$16.2M |
|
1923
UFP Industries
UFPI
$5.03B
| $19.6M | ﹤0.01% |
258,498
-37,244
| -13% | -$2.33M |
|
1924
Sabre
SABR
$892M
| $19.6M | ﹤0.01% |
1,323,198
-764,716
| -37% | -$10.4M |
|
1925
Cirrus Logic
CRUS
$6.08B
| $19.6M | ﹤0.01% |
230,601
-136,599
| -37% | -$11.8M |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 189 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 189 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.